Findings from a recent study could ultimately help doctors tailor treatment for patients with prostate cancer. Learn more about research on more personalized therapies.
The merits of PSA (prostate-specific antigen) testing for prostate cancer have long been debated. Does testing identify too many harmless, slow-growing cancers — or does it save lives? Tap or click to reveal the answer.
Disparities in health care often are thought to be the result of poverty and a related lack of access to quality health care. But clinical experience and research show that this is overly simplistic.
If you’ve been diagnosed with prostate cancer, don’t assume that surgery or radiation therapy is in your future. First, talk to your doctor about how aggressive your cancer may be. While surgery or radiation is best for some aggressive cancers, it’s not always necessary.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A new screening tool for prostate cancer has been shown to offer better accuracy than the test currently used by most physicians in the United States. The new test, called the 4Kscore™ test (OPKO Lab), offers various advantages over the more commonly used prostate specific antigen (PSA) blood test. The new test improves on these … Read More
Prostate cancer can be hard to detect. Deciding what to do about it if we find or suspect it can be even tougher, for patients and their doctors.
Listen up, gentlemen. You may be getting older and wiser. But if you’re not paying attention to — and acting on — changes in your urination habits, you’re not making the smart bet on health. You may be experiencing a weak urine stream, a sensation like urination is incomplete or an increase in the number of … Read More
Common myths about prostate cancer, including misconceptions about prostate-specific-antigen (PSA) testing and prostate surgery.
The decision on whether to actively treat prostate cancer in certain patients can be controversial. Some doctors question the wisdom of giving advanced treatment to some older patients. These patients may have a low risk of dying from the cancer itself — and little chance the treatment will provide benefit. Dying with prostate cancer rather … Read More